Hickory Point Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$276K Hold
4,795
0.17% 109
2026
Q1
$291K Buy
4,795
+200
+4% +$11.7K 0.19% 105
2025
Q4
$248K Hold
4,595
0.18% 115
2025
Q3
$207K Hold
4,595
0.15% 125
2025
Q2
$213K Hold
4,595
0.17% 121
2025
Q1
$280K Sell
4,595
-2,417
-34% -$141K 0.25% 99
2024
Q4
$397K Buy
+7,012
New +$392K 0.35% 70

Other funds holding BMY

Hickory Point Bank & Trust's BMY Position: Q2 2026 in Review

Hickory Point Bank & Trust held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 4,795 shares worth $276K. The position accounts for 0.17% of the portfolio, ranked #109.

Hickory Point Bank & Trust first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $397K in Q4 2024. 874 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Hickory Point Bank & Trust held 4,795 shares of Bristol-Myers Squibb worth $276K as of Q2 2026.
  • Hickory Point Bank & Trust left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.17% of Hickory Point Bank & Trust's portfolio in Q2 2026, its #109 holding.
  • Hickory Point Bank & Trust first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • Hickory Point Bank & Trust's Bristol-Myers Squibb position peaked at $397K in Q4 2024.
  • 874 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Hickory Point Bank & Trust's 13F filing for Q2 2026, filed 17 Jul 2026.